Stryker announced its participation in the 2026 Wells Fargo Healthcare Conference on September 8, 2026, with CFO Preston Wells and VP of Investor Relations Nick Mead participating in a fireside chat. The company also declared a quarterly dividend of $0.88 per share and reported second quarter 2026 operating results with net sales increasing 9.4% to $6.6 billion.

The global Intravascular Lithotripsy (IVL) market is projected to grow from USD 1.01 billion in 2025 to USD 4.19 billion by 2035, expanding at a 15.3% CAGR. Growth is driven by increasing prevalence of calcified coronary and peripheral artery disease, adoption of minimally invasive procedures, and expanding peripheral IVL applications. North America leads with 58% market share, while Asia-Pacific is the fastest-growing region.

Stryker Corporation announced a quarterly dividend of $0.88 per share, representing a 4.8% increase year-over-year. The company reported second quarter 2026 net sales increased 9.4% to $6.6 billion, demonstrating solid financial performance across its medical technology divisions.

The global ultrasonic aspirator market is valued at USD 194.03 million in 2025 and is projected to reach USD 376.32 million by 2035, growing at a CAGR of 6.87%. The U.S. market is expected to grow from USD 67.49 million to USD 118.90 million by 2035, driven by increasing adoption of advanced surgical technologies, rising neurosurgery procedures, and growing demand for minimally invasive surgeries. North America leads the market with 39.80% share, while Asia-Pacific registers the fastest growth at 8.83% CAGR.

The global robotic endoscopy devices market is projected to grow from USD 2.8 billion in 2025 to USD 6.5 billion by 2034, driven by increasing demand for minimally invasive procedures, technological advancements in AI-enabled navigation and imaging, and rising prevalence of gastrointestinal disorders. North America leads the market with 42% share, while Asia-Pacific is expected to witness the highest growth. Key players include Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, and others.

The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segment with 55.36% market share, with ambulatory surgical centers showing the highest growth potential.

The AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show growing segments despite tariff-related challenges.

A comprehensive patent landscape analysis of surgical navigation systems reveals 2,524 patents filed globally from 2010-2025, with the United States leading at 1,204 patents. The global market was valued at USD 8.38 billion in 2024 and is projected to reach USD 18.47 billion by 2030 at a 14% CAGR. Key drivers include AI-guided support, augmented reality, and robotic integration, with North America dominating and Asia-Pacific as the fastest-growing region. Major players include Brainlab AG, Medtronic, and Stryker.

A comprehensive RF-detection patent landscape report covering 1,248 patents filed from 2010-2024 shows the US leading with 490 patents followed closely by China with 479 patents. The global RF-detection market was valued at USD 3.5 billion in 2023 and is projected to reach USD 4.6 billion by 2032 with a 6.5% CAGR. Key application areas include military, healthcare, public safety, and transportation, with North America dominating regional sales at USD 1.6 billion in 2023.

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.

SpyGlass Pharma, a late-stage biopharmaceutical company, announced the appointment of Shannon Treviño as general counsel. Treviño brings extensive legal experience from her previous role as General Counsel at Inari Medical, where she oversaw the company's $4.9 billion acquisition by Stryker. She will support SpyGlass's Phase 3 trials for its BIM-IOL System, a drug delivery device designed to treat glaucoma and ocular hypertension.

ThruFlo Endovascular announced completion of seed funding led by Atlas MedInnovation to develop a novel bifurcated flow diverter for treating cerebral aneurysms at vessel branch points. The device addresses a significant gap in the market where approximately 60% of intracranial aneurysms occur. Proceeds will fund R&D operations, device design completion, pre-clinical studies, and FDA IDE application submission.